News

Immobilization of Thermophilic Dehydrogenase on Agarose Resins Functionalized Supports

ABT Agarose Beads have proven to be a key factor in the success of enzyme stabilization processes.

Read more

ABT has been awarded the "Innovative SME" label by the Spanish Ministry of Science, Innovation and Universities

This seal confirms the company's commitment to research, custom development and innovation in the field of bioprocessing. 

Read more

How do agarose resins contribute to genome stability to prevent genetic diseases?

The E3 ubiquitin ligase RNF2 protects polymerase ι from destabilization and represents a potential therapeutic target for diseases associated with DNA instability.

Read more

Optimization of the drug discovery process using agarose resins

Drug discovery process is the method trough which potential new therapeutic entities are identified using different scientific techniques

Read more

See you at MEDICA 2024: Accelerating diagnostic innovation

Agarose Bead Technologies will be exhibiting in Hall 3, Booth D95 from November 11-14 in Düsseldorf, Germany.

Read more

Next stop: The industry's top trade shows

Agarose Bead Technologies (ABT) is excited to announce our participation in several important trade fairs this October.

Read more

Agarose Bead Technologies expands facility to meet rising global demand for novel therapies market

Agarose Bead Technologies has enhanced its Burgos facility by boosting its agarose resin production to 100,000 liters annually to position itself as a powerhouse in the novel therapies market.

Read more

See you at Bioprocess International Conference and Exhibition 2024

ABT will be exhibiting at one of the most prestigious events in the bioprocessing industry, the Bioprocess International Conference. This prestigious event will be held...

Read more

The significance of protein purification in the fight against cancer

Discover how ABT's Nickel NTA Agarose Resin is paving the way for new immunotherapy breakthroughs that could transform treatments for immune-related diseases...

Read more

We’re celebrating: Our brand-NEW Website is live!

Our new website is more than just a visual upgrade. It represents our commitment to providing the best possible resources and information to our clients and partners in the bioprocessing and biopharmaceutical industries...

Read more

"ABT’s beads allowed fine control over immobilization conditions, including surface functionalization, porosity, and loading capacity."

In this study, a self-sufficient heterogeneous biocatalyst was developed for the asymmetric reduction of β-keto esters, employing the enzyme Tt27-HBDH from Thermus thermophilus HB27.

A key factor in the success of this system was the immobilization strategy (Figure 1) on porous agarose beads supplied by Agarose Bead Technologies (ABT).

IMMOBILIZATION ON FUNCTIONALIZED AGAROSE BEADS

The Tt27-HBDH enzyme was immobilized using different strategies on agarose-based functionalized supports (6% BCL and 4% BCL), evaluating both reversible methods (such as ionic adsorption on agarose activated with polyethyleneimine, PEI, or with polyallylamine, PAA) and covalent methods (agarose activated with aldehyde groups, AG–G). Covalent immobilization on AG–G proved to be the most robust and effective, with yields exceeding 94% and recovered activity ranging from 50–85%, depending on the method.

A key step was the subsequent coating with PEI, which not only enhanced enzyme stability under extreme conditions (such as 60 °C, pH 4.5, and 20% isopropanol) but also enabled co-immobilization of the NADH cofactor. This polymeric coating creates a hydrophilic, positively charged environment that stabilizes the quaternary structure of the enzyme and facilitates cofactor retention.

Figure 1. (A) Electrostatic surface of Tt27-HBDH hexamer 3D-model using Bluues server. (B) Asymmetric reduction of EAA catalysed by soluble and immobilised multi-functional biocatalysts.

CUSTOMIZATION ADVANTAGES

Selecting the appropriate agarose resin proved to be critical. At ABT, the customization service offers partners a close collaboration with our organic chemists, who not only help design the tailored bead but also provide ongoing support throughout the development process, working alongside you to ensure optimal results.

ABT’s beads allowed fine control over immobilization conditions, including surface functionalization, porosity, and loading capacity. This highlights the value of ABT's customization service, which allows for the adaptation of key parameters such as:

  • Particle size
  • Ligand type
  • Ligand concentration
  • Porosity
  • Activation chemistry

These features make ABT's supports ideal for applications where stability, reusability, and efficiency of the biocatalyst are essential.

  1. Alejandro H. Orrego, Daniel Andrés-Sanz, Susana Velasco-Lozano, Mercedes Sanchez-Costa, José Berenguer, José M. Guisan, Javier Rocha-Martin and Fernando López-Gallego. Self-sufficient asymmetric reduction of β-ketoesters catalysed by a novel and robust thermophilic alcohol dehydrogenase co-immobilised with NADH. Catal. Sci. Technol., 2021, 11, 3217-3230.
Cookie consent
Product added to wishlist